1995
DOI: 10.1016/0020-2452(96)81482-5
|View full text |Cite
|
Sign up to set email alerts
|

Controversies surrounding current therapies for sepsis syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

1996
1996
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 147 publications
0
6
0
Order By: Relevance
“…Eicosapentaenoic acid -enriched phospholipids extracted from sea cucumber Cucumaria frondosa, also has an inhibition effect on the reactive oxygenated species [89,[98][99][100][101][102][103][104][105]. Wu et al [89] remarks that this antioxidant compound alters the metabolic way of the mitochondrial apoptosis [89].…”
Section: Therapy With Antioxidantsmentioning
confidence: 99%
“…Eicosapentaenoic acid -enriched phospholipids extracted from sea cucumber Cucumaria frondosa, also has an inhibition effect on the reactive oxygenated species [89,[98][99][100][101][102][103][104][105]. Wu et al [89] remarks that this antioxidant compound alters the metabolic way of the mitochondrial apoptosis [89].…”
Section: Therapy With Antioxidantsmentioning
confidence: 99%
“…A closer friendship and collaboration were established between Pasteur and Jacobsen [39] and their laboratories, which initiated “the revanche project” [40, 41] aiming to make better beer than the German's. Pasteur's only son Jean Baptiste was enrolled in the French‐German war in 1870–1871 and injured, and when the Germans prevailed the French army at Sedan and besieged Paris, why the citizens in Paris ousted the government, it had to escape from the city in balloons.…”
Section: The Studies On Beer Production and Its Impact On Success Of ...mentioning
confidence: 99%
“…1, 6, 9, and 10). We thank her also for the gifts of Bruno Latour book from 1994—“Pasteur – une science, un style, un siècle.” My acknowledgement goes also to a third Pasteurian, Jean‐Marc Cavaillon (jean-marc.cavaillon@pasteur.fr), author to a recent review on Pasteur [12] for multiple communications and advices, and for access to his PowerPoint presentation [40]. Finally, my earlier supervisor emeritus docent Thorkild C. Bøg‐Hansen from University of Copenhagen is acknowledged for his comments and proposals to the final article.…”
mentioning
confidence: 99%
“…These risks and limitations could theoretically be overcome with MAbs of human origin (156), but despite intense efforts (12,20,43,60), human MAbs from hybridomas and lymphocyte cell lines have proven too difficult to generate easily. Finally and perhaps most importantly, the failures of clinical trials of the anti-LPS mouse IgM E5 MAb from Xoma (Berkeley, CA, USA) (completed between 1992 and 1993) and the human IgM HA-1A from Stanford/Centocor (Leiden, The Netherlands) for septic shock (27) combined to dampen interest in MAbs as therapeutic drugs.…”
Section: Introductionmentioning
confidence: 99%